Cell Therapy Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.celixir.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)An Investigation of Tendoncel, a Novel Topical Platelet Lysate Gel, in the Treatment of Lateral Epicondylitis
Phase 2
Completed
- Conditions
- Lateral Epicondylitis
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- Cell Therapy Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03811145
- Locations
- 🇬🇷
Orthopaedic Clinic of Aristotle University of Thessaloniki, General Hospital of Papanikolaou, Thessaloniki, Greece
A Trial of Cardiac Injections of iMP Cells During CABG Surgery
Phase 2
- Conditions
- Myocardial Fibrosis
- First Posted Date
- 2018-05-03
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Cell Therapy Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT03515291
News
No news found